OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma
Lingzhi Li, Lei Nie, Alexa A Jordan, et al.
Haematologica (2022) Vol. 108, Iss. 6, pp. 1616-1627
Open Access | Times Cited: 11

Showing 11 citing articles:

Role of Ubiquitination-driven Metabolisms in Oncogenesis and Cancer Therapy
Dongqin Yang, Can Yang, Linlin Huang, et al.
Seminars in Cancer Biology (2025)
Closed Access | Times Cited: 1

Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC
Haotian Qin, Weibei Sheng, Geng Zhang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 10

BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
Xin Liu, Yufan Lin, Qiqi Zhuang, et al.
Blood Reviews (2025), pp. 101273-101273
Closed Access

Spleen cancer: Current status of preclinical research
Gaurav Tiwari, Surender Beniwal, Shashi Ravi Suman Rudrangi, et al.
Elsevier eBooks (2025), pp. 45-68
Closed Access

Yuanhuacine suppresses head and neck cancer growth by promoting ASCT2 degradation and inhibiting glutamine uptake
Xinyi Chen, Xin Chen, Xiaohui Liang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
Yuyang Pang, Tingxun Lu, Zijun Y. Xu‐Monette, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5493-5493
Open Access | Times Cited: 9

Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1
Guangzhao Zhu, Fangxia Guan, Shenglei Li, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 897-911
Closed Access | Times Cited: 3

Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress
Beatriz Gomez Solsona, Heike Horn, Anja Schmitt, et al.
Blood Advances (2023) Vol. 7, Iss. 24, pp. 7433-7444
Open Access | Times Cited: 4

Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma
Imani Bijou, Yang Liu, Dong Lu, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0289902-e0289902
Open Access

Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma
Imani Bijou, Yang Liu, Dong Lu, et al.
Research Square (Research Square) (2023)
Open Access

Targeting glutaminase to starve lymphoma cells
Charles Dumontet
Haematologica (2022) Vol. 108, Iss. 6, pp. 1468-1469
Open Access

Page 1

Scroll to top